OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells

Overview

Journal Mol Cells

Publisher Elsevier

Specialties Cell Biology
Molecular Biology

Date 2019 Jan 10

PMID 30622231

Citations 4

Authors

Sang-Hun Choi

Jun-Kyum Kim

Hee-Young Jeon

Kiyoung Eun

Hyunggee Kim

Affiliations

Soon will be listed here.

Abstract

OCT4, also known as POU5F1 (POU domain class 5 transcription factor 1), is a transcription factor that acts as a master regulator of pluripotency in embryonic stem cells and is one of the reprogramming factors required for generating induced pluripotent stem cells. The human OCT4 encodes three isoforms, OCT4A, OCT4B, and OCT4B1, which are generated by alternative splicing. Currently, the functions and expression patterns of OCT4B remain largely unknown in malignancies, especially in human glioblastomas. Here, we demonstrated the function of OCT4B in human glioblastomas. Among the isoform of OCT4B, OCT4B-190 (OCT4B) was highly expressed in human glioblastoma stem cells and glioblastoma cells and was mainly detected in the cytoplasm rather than the nucleus. Overexpression of OCT4B promoted colony formation of glioblastoma cells when grown in soft agar culture conditions. Clinical data analysis revealed that patients with gliomas that expressed OCT4B at high levels had a poorer prognosis than patients with gliomas that expressed OCT4B at low levels. Thus, OCT4B may play a crucial role in regulating cancer cell survival and adaption in a rigid environment.

Citing Articles

Pseudogene OCT4-pg5 upregulates OCT4B expression to promote bladder cancer progression by competing with miR-145-5p.

Zhou W, Yang Y, Wang W, Yang C, Cao Z, Lin X Cell Cycle. 2024; 23(6):645-661.

PMID: 38842275 PMC: 11229759. DOI: 10.1080/15384101.2024.2353554.

Catalase Overexpression Drives an Aggressive Phenotype in Glioblastoma.

Flor S, Oliva C, Ali M, Coleman K, Greenlee J, Jones K Antioxidants (Basel). 2021; 10(12).

PMID: 34943091 PMC: 8750785. DOI: 10.3390/antiox10121988.

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of and genes in glioma SCs .

Aslam N, Abusharieh E, Abuarqoub D, Ali D, Al-Hattab D, Wehaibi S Mol Ther Oncolytics. 2021; 20:147-165.

PMID: 33575478 PMC: 7851499. DOI: 10.1016/j.omto.2020.11.005.

Evaluation of the In Vitro Damage Caused by Lipid Factors on Stem Cells from a Female Rat Model of Type 2 Diabetes/Obesity and Stress Urinary Incontinence.

Kovanecz I, Gelfand R, Sharifzad S, Ohanian A, DeCastro W, Cooper C Int J Mol Sci. 2020; 21(14).

PMID: 32708907 PMC: 7404394. DOI: 10.3390/ijms21145045.

References

Takeda J, Seino S, Bell G . Human Oct3 gene family: cDNA sequences, alternative splicing, gene organization, chromosomal location, and expression at low levels in adult tissues. Nucleic Acids Res. 1992; 20(17):4613-20. PMC: 334192. DOI: 10.1093/nar/20.17.4613. View

Subramanian A, Tamayo P, Mootha V, Mukherjee S, Ebert B, Gillette M . Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102(43):15545-50. PMC: 1239896. DOI: 10.1073/pnas.0506580102. View

Han S, Roman J . Fibronectin induces cell proliferation and inhibits apoptosis in human bronchial epithelial cells: pro-oncogenic effects mediated by PI3-kinase and NF-kappa B. Oncogene. 2006; 25(31):4341-9. DOI: 10.1038/sj.onc.1209460. View

Takahashi K, Yamanaka S . Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126(4):663-76. DOI: 10.1016/j.cell.2006.07.024. View

Lee J, Kim H, Rho J, Han Y, Kim J . The human OCT-4 isoforms differ in their ability to confer self-renewal. J Biol Chem. 2006; 281(44):33554-65. DOI: 10.1074/jbc.M603937200. View

Ben-Porath I, Thomson M, Carey V, Ge R, Bell G, Regev A . An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008; 40(5):499-507. PMC: 2912221. DOI: 10.1038/ng.127. View

Atlasi Y, Mowla S, Ziaee S, Gokhale P, Andrews P . OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells. 2008; 26(12):3068-74. DOI: 10.1634/stemcells.2008-0530. View

Du Z, Jia D, Liu S, Wang F, Li G, Zhang Y . Oct4 is expressed in human gliomas and promotes colony formation in glioma cells. Glia. 2008; 57(7):724-33. DOI: 10.1002/glia.20800. View

Butcher D, Alliston T, Weaver V . A tense situation: forcing tumour progression. Nat Rev Cancer. 2009; 9(2):108-22. PMC: 2649117. DOI: 10.1038/nrc2544. View

10.

Wang X, Zhao Y, Xiao Z, Chen B, Wei Z, Wang B . Alternative translation of OCT4 by an internal ribosome entry site and its novel function in stress response. Stem Cells. 2009; 27(6):1265-75. DOI: 10.1002/stem.58. View

11.

Verhaak R, Hoadley K, Purdom E, Wang V, Qi Y, Wilkerson M . Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010; 17(1):98-110. PMC: 2818769. DOI: 10.1016/j.ccr.2009.12.020. View

12.

Wang X, Dai J . Concise review: isoforms of OCT4 contribute to the confusing diversity in stem cell biology. Stem Cells. 2010; 28(5):885-93. PMC: 2962909. DOI: 10.1002/stem.419. View

13.

Gao Y, Wang X, Han J, Xiao Z, Chen B, Su G . The novel OCT4 spliced variant OCT4B1 can generate three protein isoforms by alternative splicing into OCT4B. J Genet Genomics. 2010; 37(7):461-5. DOI: 10.1016/S1673-8527(09)60065-5. View

14.

Asadi M, Mowla S, Fathi F, Aleyasin A, Asadzadeh J, Atlasi Y . OCT4B1, a novel spliced variant of OCT4, is highly expressed in gastric cancer and acts as an antiapoptotic factor. Int J Cancer. 2010; 128(11):2645-52. DOI: 10.1002/ijc.25643. View

15.

Abiko K, Mandai M, Hamanishi J, Matsumura N, Baba T, Horiuchi A . Oct4 expression in immature teratoma of the ovary: relevance to histologic grade and degree of differentiation. Am J Surg Pathol. 2010; 34(12):1842-8. DOI: 10.1097/PAS.0b013e3181fcd707. View

16.

Gazouli M, Roubelakis M, Theodoropoulos G, Papailiou J, Vaiopoulou A, Pappa K . OCT4 spliced variant OCT4B1 is expressed in human colorectal cancer. Mol Carcinog. 2011; 51(2):165-73. DOI: 10.1002/mc.20773. View

17.

Rijlaarsdam M, van Herk H, Gillis A, Stoop H, Jenster G, Martens J . Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours. Br J Cancer. 2011; 105(6):854-63. PMC: 3171004. DOI: 10.1038/bjc.2011.270. View

18.

Gao Y, Wei J, Han J, Wang X, Su G, Zhao Y . The novel function of OCT4B isoform-265 in genotoxic stress. Stem Cells. 2012; 30(4):665-72. DOI: 10.1002/stem.1034. View

19.

Kumar S, Liu S, Lu H, Zhang H, Zhang P, Gimotty P . Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation. Oncogene. 2012; 31(47):4898-911. PMC: 3343184. DOI: 10.1038/onc.2011.656. View

20.

Asadzadeh J, Asadi M, Shakhssalim N, Rafiee M, Kalhor H, Tavallaei M . A plausible anti-apoptotic role of up-regulated OCT4B1 in bladder tumors. Urol J. 2012; 9(3):574-80. View